DOJ Wins Bids To End FCA Suits Targeting Eli Lilly, Bayer

Law360 (September 30, 2019, 8:20 PM EDT) -- The federal government’s interest in conserving resources is a good enough reason for the U.S. Department of Justice to torpedo whistleblower False Claims Act suits, a Texas federal judge has ruled in axing FCA cases accusing Eli Lilly and Bayer of funneling kickbacks to doctors.

U.S. District Judge Robert W. Schroeder III on Friday granted the DOJ's motions to dismiss a pair of suits from affiliates of the National Healthcare Analysis Group, which specializes in bringing FCA suits. The suits accused Eli Lilly and Co. Inc. and Bayer Corp. of improperly encouraging doctors to write prescriptions by supplying free nursing services...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!